Sara Inga Liin

Sara Inga Liin

Auto-generated profile, based on publicly available information

Sara Inga Liin

Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2017 in Frontiers in Physiology
Verified
Journal Article
Open access
FEFredrik Elinder
Fredrik Elinder
SLSara I. Liin
Sara I. Liin
Polyunsaturated fatty acids (PUFAs) act on most ion channels, thereby having significant physiological and pharmacological effects. In this review we summarize data from numerous PUFAs on voltage-gated ion channels containing one or several voltage-sensor domains, such as voltage-gated sodium (NaV), potassium (KV), calcium (CaV), and proton (HV) channels, as well as calcium-activated potassium (KCa), and transient receptor potential (TRP) channels. Some effects of fatty acids appear to be channel specific, whereas others seem to be more general. Common features for the fatty acids to act on the ion channels are at least two double bonds in cis geometry and a charged carboxyl group. In total we identify and label five different sites for the PUFAs. PUFA site 1: The intracellular cavity. Binding of PUFA reduces the current, sometimes as a time-dependent block, inducing an apparent inactivation. PUFA site 2: The extracellular entrance to the pore. Binding leads to a block of the channel. PUFA site 3: The intracellular gate. Binding to this site can bend the gate open and increase the current. PUFA site 4: The interface between the extracellular leaflet of the lipid bilayer and the voltage-sensor domain. Binding to this site leads to an opening of the channel via an electrostatic attraction between the negatively charged PUFA and the positively charged voltage sensor. PUFA site 5: The interface between the extracellular leaflet of the lipid bilayer and the pore domain. Binding to this site affects slow inactivation. This mapping of functional PUFA sites can form the basis for physiological and pharmacological modifications of voltage-gated ion channels.

28 April 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
RBRene Barro-Soria
Rene Barro-Soria
SRSantiago Rebolledo
Santiago Rebolledo
SLSara I. Liin
Sara I. Liin
MPMarta E. Perez
Marta E. Perez
KSKevin J. Sampson
Kevin J. Sampson
HLH. Peter Larsson
H. Peter Larsson
The functional properties of KCNQ1 channels are highly dependent on associated KCNE-β subunits. Mutations in KCNQ1 or KCNE subunits can cause congenital channelopathies, such as deafness, cardiac arrhythmias and epilepsy. The mechanism by which KCNE1-β subunits slow the kinetics of KCNQ1 channels is a matter of current controversy. Here we show that KCNQ1/KCNE1 channel activation occurs in two steps: first, mutually independent voltage sensor movements in the four KCNQ1 subunits generate the main gating charge movement and underlie the initial delay in the activation time course of KCNQ1/KCNE1 currents. Second, a slower and concerted conformational change of all four voltage sensors and the gate, which opens the KCNQ1/KCNE1 channel. Our data show that KCNE1 divides the voltage sensor movement into two steps with widely different voltage dependences and kinetics. The two voltage sensor steps in KCNQ1/KCNE1 channels can be pharmacologically isolated and further separated by a disease-causing mutation.

17 July 2018 in eLife
Verified
Journal Article
Open access
JLJohan E Larsson
Johan E Larsson
HLH. Peter Larsson
H. Peter Larsson
SLSara I Liin
Sara I Liin
The voltage-gated potassium channel KV7.1 and the auxiliary subunit KCNE1 together form the cardiac IKs channel, which is a proposed target for future anti-arrhythmic drugs. We previously showed that polyunsaturated fatty acids (PUFAs) activate KV7.1 via an electrostatic mechanism. The activating effect was abolished when KV7.1 was co-expressed with KCNE1, as KCNE1 renders PUFAs ineffective by promoting PUFA protonation. PUFA protonation reduces the potential of PUFAs as anti-arrhythmic compounds. It is unknown how KCNE1 promotes PUFA protonation. Here, we found that neutralization of negatively charged residues in the S5-P-helix loop of KV7.1 restored PUFA effects on KV7.1 co-expressed with KCNE1 in Xenopus oocytes. We propose that KCNE1 moves the S5-P-helix loop of KV7.1 towards the PUFA-binding site, which indirectly causes PUFA protonation, thereby reducing the effect of PUFAs on KV7.1. This mechanistic understanding of how KCNE1 alters KV7.1 pharmacology is essential for development of drugs targeting the IKs channel.

21 April 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SLSara I. Liin
Sara I. Liin
MEMalin Silverå Ejneby
Malin Silverå Ejneby
RBRene Barro-Soria
Rene Barro-Soria
MSMark Alexander Skarsfeldt
Mark Alexander Skarsfeldt
JLJohan E. Larsson
Johan E. Larsson
FEFredrik Elinder
Fredrik Elinder
Significance: More than 300 mutations in the genes encoding the cardiac I Ks channel have been identified in patients with cardiac arrhythmia. These mutations cause either loss of function or gain of function of the I Ks channel. This study describes how polyunsaturated fatty acids and their analogues activate or inhibit the I Ks channel. These modulators can restore rhythmic firing in arrhythmic firing cardiac myocytes and restore prolonged QT interval in guinea pig hearts. The study also describes a mechanism by which an auxiliary β-subunit alters the pharmacological sensitivity of the I Ks channel. Our findings may form the basis for future design of antiarrhythmic compounds that target I Ks channels for treating different cardiac arrhythmias caused by mutations in the I Ks channel.

1 September 2018 in Cell Reports
Verified
Journal Article
Open access
SLSara I. Liin
Sara I. Liin
SYSamira Yazdi
Samira Yazdi
RRRosamary Ramentol
Rosamary Ramentol
RBRene Barro-Soria
Rene Barro-Soria
HLH. Peter Larsson
H. Peter Larsson
Polyunsaturated fatty acid (PUFA) analogs represent a new class of potential anti-arrhythmic KV7.1 and KV7.1+KCNE1 channel activators. In this study, we describe dual independent activating effects of negatively charged PUFA analogs on KV7.1 and KV7.1+KCNE1 that are dependent on discrete channel motifs. PUFA analogs are critically dependent on K326 in S6 of KV7.1 to increase the maximum conductance and critically dependent on specific S4 arginines in KV7.1 to shift the voltage dependence of channel opening toward negative voltages. Our findings provide insights into how KV7.1+KCNE1 activators may interact electrostatically both with the pore domain and the voltage-sensing domain to augment channel activity. We believe that the molecular understanding of how PUFA analogs induce dual independent activating effects is an important step toward the development of effective anti-arrhythmic drugs that target KV7.1 channels.

13 January 2014 in Journal of General Physiology
Verified
Journal Article
Open access
NONina E. Ottosson
Nina E. Ottosson
SLSara I. Liin
Sara I. Liin
FEFredrik Elinder
Fredrik Elinder
Polyunsaturated fatty acids modulate the voltage dependence of several voltage-gated ion channels, thereby being potent modifiers of cellular excitability. Detailed knowledge of this molecular mechanism can be used in designing a new class of small-molecule compounds against hyperexcitability diseases. Here, we show that arginines on one side of the helical K-channel voltage sensor S4 increased the sensitivity to docosahexaenoic acid (DHA), whereas arginines on the opposing side decreased this sensitivity. Glutamates had opposite effects. In addition, a positively charged DHA-like molecule, arachidonyl amine, had opposite effects to the negatively charged DHA. This suggests that S4 rotates to open the channel and that DHA electrostatically affects this rotation. A channel with arginines in positions 356, 359, and 362 was extremely sensitive to DHA: 70 µM DHA at pH 9.0 increased the current >500 times at negative voltages compared with wild type (WT). The small-molecule compound pimaric acid, a novel Shaker channel opener, opened the WT channel. The 356R/359R/362R channel drastically increased this effect, suggesting it to be instrumental in future drug screening.